tirzepatide and osteoporosis Tirzepatide, a dual GLP-1 GIP receptor agonist, promotes bone loss in obese mice via gut microbial-related metabolites Effects of Glucagon-Like Peptide-1 receptor

This professional oversight provides safety, accountability, and the best chance for lasting success

Ozempic and Tirzepatide belong to the GLP-1 receptor agonist class, mimicking natural hormones that enhance insulin secretion and suppress glucagon, effectively lowering blood sugar levels

There are two common reconstitution approaches for a 10mg vial

Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the action of these incretin hormones to enhance insulin secretion, suppress glucagon release, and slow gastric emptying

GLP-1 is a naturally occurring hormone produced in your small intestine